Lv1
82 积分 2021-01-07 加入
First-Line Sunvozertinib in NSCLC with EGFR Exon 20 Insertion Mutations
22天前
已完结
Camrelizumab plus CAPOX with camrelizumab based maintenance versus CAPOX alone as initial treatment for gastric or gastro-oesophageal junction adenocarcinoma: randomised phase 3 trial
3个月前
已完结
Disruptive Analysis of Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer: Clinical and Therapeutic Distinctions Between Low- and Mid-Rectal Cancers
3个月前
已关闭
Disruptive Analysis of Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer: Clinical and Therapeutic Distinctions Between Low- and Mid-Rectal Cancers
3个月前
已关闭
First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 tria
4个月前
已完结
Structured Exercise after Adjuvant Chemotherapy for Colon Cancer
4个月前
已完结
Risk Prediction Model for Development of Heart Failure or Cardiomyopathy After Breast Cancer Treatment
4个月前
已完结
Small Cell Lung Cancer: A Review
5个月前
已完结
Unraveling the role of adjuvant chemotherapy in elderly triple-negative breast cancer: Insights from competing risk analysis using SEER data
5个月前
已关闭
Cutaneous Melanoma: A Review
6个月前
已完结
皖公网安备34019202002308
